Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia.
D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use*; D001772:Blood Cell Count; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D009504:Neutrophils; D012075:Remission, Spontaneous; D013997:Time Factors
D003561:Cytarabine; D001215:Asparaginase